A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
28
Participants
Timeline
Start Date
July 9, 2019
Primary Completion Date
October 3, 2019
Study Completion Date
October 3, 2019
Conditions
Elderly Study ParticipantsAdult Study Participants
Interventions
DRUG
Padsevonil
Padsevonil will be administered in predefined dosages.
Trial Locations (1)
78209
Up0053 001, San Antonio
All Listed Sponsors
lead
UCB Biopharma S.P.R.L.
INDUSTRY
NCT04013191 - A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants | Biotech Hunter | Biotech Hunter